BRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Results of Operations and Financial Condition

BRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02. Results of Operations and Financial Condition.

On February13, 2017, Bruker Corporation issued a press release
announcing combined financial results as of and for the three and
twelve months ended December31, 2016 and providing initial
guidance for its 2017 fiscal year. A copy of the press release is
attached hereto as Exhibit99.1.

The information in Item 2.02 of this Current Report on Form8-K,
including Exhibit99.1, is being furnished and shall not be deemed
filed for purposes of Section18 of the Securities Exchange Act of
1934, as amended, and shall not be incorporated by reference into
any filing of the company under the Securities Act of 1933, as
amended, except as shall be expressly set forth by specific
reference in such filing.

Cautionary Note Regarding Forward-Looking
Statements

Except for historical information contained in the press release
attached hereto as Exhibit99.1, the press release contains
forward-looking statements that involve certain risks and
uncertainties that could cause actual results to differ
materially from those indicated by these statements. Please refer
to the cautionary note contained in the press release under the
heading Forward Looking Statements for additional information
regarding these forward-looking statements.

Section9 Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibits

Number

99.1

Press release dated February13, 2017.


About BRUKER CORPORATION (NASDAQ:BRKR)

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive (CBRNE) detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

BRUKER CORPORATION (NASDAQ:BRKR) Recent Trading Information

BRUKER CORPORATION (NASDAQ:BRKR) closed its last trading session up +0.12 at 25.10 with 991,056 shares trading hands.

An ad to help with our costs